Cephalalgia
@jcephalalgia
The official journal for the International Headache Society @ihs_official Impact Factor 5 - Gold Open Access January 2023
ID: 2348818939
http://cep.sagepub.com/ 17-02-2014 17:28:23
1,1K Tweet
3,3K Takipçi
423 Takip Edilen
Chronic migraine treatment is challenging. This study explores combining OnabotulinumtoxinA and anti-CGRP monoclonal antibodies. Results show mAbs' efficacy and safety in BT-A-treated patients, particularly in partial responders. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain
